370 related articles for article (PubMed ID: 30653577)
1. The effect of sodium butyrate and cisplatin on expression of EMT markers.
Mrkvicova A; Chmelarova M; Peterova E; Havelek R; Baranova I; Kazimirova P; Rudolf E; Rezacova M
PLoS One; 2019; 14(1):e0210889. PubMed ID: 30653577
[TBL] [Abstract][Full Text] [Related]
2. Anticancer effects of sodium butyrate on hepatocellular carcinoma cells in vitro.
Wang HG; Huang XD; Shen P; Li LR; Xue HT; Ji GZ
Int J Mol Med; 2013 Apr; 31(4):967-74. PubMed ID: 23440283
[TBL] [Abstract][Full Text] [Related]
3. Investigation of role of CpG methylation in some epithelial mesenchymal transition gene in a chemoresistant ovarian cancer cell line.
Alghamian Y; Soukkarieh C; Abbady AQ; Murad H
Sci Rep; 2022 May; 12(1):7494. PubMed ID: 35523936
[TBL] [Abstract][Full Text] [Related]
4. Impact of Selected Signaling Proteins on SNAIL 1 and SNAIL 2 Expression in Ovarian Cancer Cell Lines in Relation to Cells' Cisplatin Resistance and EMT Markers Level.
Kielbik M; Szulc-Kielbik I; Klink M
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33478150
[TBL] [Abstract][Full Text] [Related]
5. Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer.
Aghdassi A; Sendler M; Guenther A; Mayerle J; Behn CO; Heidecke CD; Friess H; Büchler M; Evert M; Lerch MM; Weiss FU
Gut; 2012 Mar; 61(3):439-48. PubMed ID: 22147512
[TBL] [Abstract][Full Text] [Related]
6. Pracinostat (SB939), a histone deacetylase inhibitor, suppresses breast cancer metastasis and growth by inactivating the IL-6/STAT3 signalling pathways.
Chen J; Li N; Liu B; Ling J; Yang W; Pang X; Li T
Life Sci; 2020 May; 248():117469. PubMed ID: 32109485
[TBL] [Abstract][Full Text] [Related]
7. Histone hyperacetylation up-regulates protein kinase Cδ in dopaminergic neurons to induce cell death: relevance to epigenetic mechanisms of neurodegeneration in Parkinson disease.
Jin H; Kanthasamy A; Harischandra DS; Kondru N; Ghosh A; Panicker N; Anantharam V; Rana A; Kanthasamy AG
J Biol Chem; 2014 Dec; 289(50):34743-67. PubMed ID: 25342743
[TBL] [Abstract][Full Text] [Related]
8. HDAC1 Silencing in Ovarian Cancer Enhances the Chemotherapy Response.
Liu X; Yu Y; Zhang J; Lu C; Wang L; Liu P; Song H
Cell Physiol Biochem; 2018; 48(4):1505-1518. PubMed ID: 30071534
[TBL] [Abstract][Full Text] [Related]
9. Smoking induces epithelial-to-mesenchymal transition in non-small cell lung cancer through HDAC-mediated downregulation of E-cadherin.
Nagathihalli NS; Massion PP; Gonzalez AL; Lu P; Datta PK
Mol Cancer Ther; 2012 Nov; 11(11):2362-72. PubMed ID: 22933707
[TBL] [Abstract][Full Text] [Related]
10. [Investigation of epithelial-mesenchymal transition induced by cisplatin on human laryngeal resistant cancer cells].
Gong XR; Yu F; Zhou YB
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Dec; 31(23):1839-1843. PubMed ID: 29798399
[No Abstract] [Full Text] [Related]
11. TGF-β induces global changes in DNA methylation during the epithelial-to-mesenchymal transition in ovarian cancer cells.
Cardenas H; Vieth E; Lee J; Segar M; Liu Y; Nephew KP; Matei D
Epigenetics; 2014 Nov; 9(11):1461-72. PubMed ID: 25470663
[TBL] [Abstract][Full Text] [Related]
12. TET1 promotes cisplatin-resistance via demethylating the vimentin promoter in ovarian cancer.
Han X; Zhou Y; You Y; Lu J; Wang L; Hou H; Li J; Chen W; Zhao L; Li X
Cell Biol Int; 2017 Apr; 41(4):405-414. PubMed ID: 28150354
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin.
Shah P; Gau Y; Sabnis G
Breast Cancer Res Treat; 2014 Jan; 143(1):99-111. PubMed ID: 24305977
[TBL] [Abstract][Full Text] [Related]
14. Anticancer efficacy of cisplatin and trichostatin A or 5-aza-2'-deoxycytidine on ovarian cancer.
Meng F; Sun G; Zhong M; Yu Y; Brewer MA
Br J Cancer; 2013 Feb; 108(3):579-86. PubMed ID: 23370212
[TBL] [Abstract][Full Text] [Related]
15. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
[TBL] [Abstract][Full Text] [Related]
16. CCR7 preservation via histone deacetylase inhibition promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells.
Yang L; Chang Y; Cao P
Exp Cell Res; 2018 Oct; 371(1):231-237. PubMed ID: 30107147
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic silencing of genes enhanced by collective role of reactive oxygen species and MAPK signaling downstream ERK/Snail axis: Ectopic application of hydrogen peroxide repress CDH1 gene by enhanced DNA methyltransferase activity in human breast cancer.
Pradhan N; Parbin S; Kar S; Das L; Kirtana R; Suma Seshadri G; Sengupta D; Deb M; Kausar C; Patra SK
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1651-1665. PubMed ID: 30954555
[TBL] [Abstract][Full Text] [Related]
18. Epithelial‑mesenchymal transition induced by bone morphogenetic protein 9 hinders cisplatin efficacy in ovarian cancer cells.
Wang Y; Yang B; Zhao J; Yu X; Liu X; Zhang L; Zhang Y; Li X; Zhai Z
Mol Med Rep; 2019 Mar; 19(3):1501-1508. PubMed ID: 30628686
[TBL] [Abstract][Full Text] [Related]
19. Dual targeting of GSK3B and HDACs reduces tumor growth and improves survival in an ovarian cancer mouse model.
Taylan E; Zayou F; Murali R; Karlan BY; Pandol SJ; Edderkaoui M; Orsulic S
Gynecol Oncol; 2020 Oct; 159(1):277-284. PubMed ID: 32698955
[TBL] [Abstract][Full Text] [Related]
20. Chidamide alleviates TGF-β-induced epithelial-mesenchymal transition in lung cancer cell lines.
Lin SH; Wang BY; Lin CH; Chien PJ; Wu YF; Ko JL; Chen JJ
Mol Biol Rep; 2016 Jul; 43(7):687-95. PubMed ID: 27188428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
